A partnership between two CRISPR pioneers will provide the global scientific community with GMP MAD7™ Nuclease Aldevron®, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech industry, along with Inscripta®, a life science technology company dedicated to making CRISPR-based genome engineering accessible to any research lab, […]
Oxford Nanopore technology will enable the 1000 Genomes Project, spearheaded by researchers at the University of Washington and Seattle Children’s Hospital, to gain greater genomic insights into clinically relevant variants by providing accurate, affordable, scalable and comprehensive information Uncovering new discoveries across the genome Oxford Nanopore sequencing technology is to be used by a group […]
BLIRT SA, a biotech firm specializing in producing high-quality enzymes and reagents used in life sciences and global diagnostics, has changed its ownership structure. International biotech company QIAGEN has acquired over 96% of the shares of BLIRT. “Over recent years, we have intensively grown our business,” said Marian Popinigis, CEO of BLIRT SA. “We have invested, observed […]
Åsa Hillsten has been appointed SVP and Head of IR at BICO and will be a member of the company’s executive management This newly created position constitutes a step in BICO’s continued efforts to increase the service level to the market, improve the clarity of its communication and clarify its business model for the investor […]
Dr. Eva Pisa proposed as a new member to the Supervisory Board, contributes significant leadership experience in Life Science and Molecular Diagnostics industry All seven current Supervisory Board members to stand for re-election for one-year terms Annual General Meeting to be held on June 23, 2022, in Venlo, the Netherlands VENLO, the Netherlands — QIAGEN […]
BLIRT adds new R&D and manufacturing capabilities for customized and standardized recombinant enzymes, as well as molecular biology reagents Strengthens QIAGEN’s sample technologies business, one of the company’s five pillars of growth, also with additional global production capacities and broader commercial reach 96% majority stake acquired in BLIRT S.A. through the transaction with a group […]
PARSIPPANY, NJ — Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, has announced that in association with Miroculus, Inc., a developer of revolutionary tools for personal lab automation, it will optimize next generation sequencing (NGS) library preparation utilizing its digital microfluidics (DMF) technology. Also working in conjunction with […]
Collaboration will accelerate plasmid optimization and sourcing services for new and existing viral vector and mRNA-based vaccine and therapeutic customers RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, and Cytovance Biologics, Inc., a biologics contract development and […]
Singular’s G4 Sequencing Platform with NVIDIA Clara Parabricks secondary analysis tools delivers accelerated results for prominent applications including whole genome sequencing LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the company is collaborating with NVIDIA to […]
LA JOLLA, Calif., May 10, 2022 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the formation of its scientific advisory board (SAB). The SAB comprises a distinguished group of academic and industry experts who will advise on […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
